Mail

CVS - CVS Health Corporation

NYSE - Nasdaq Real Time Price. Currency in USD

53.37

+0.94 (+1.79%)

As of 2:05PM EDT. Market open.

Stock chart is not supported by your current browser

Previous close	52.43
Open	52.50
Bid	53.43 x 1300
Ask	53.44 x 1300
Day's range	52.10 - 53.67
52-week range	51.77 - 82.15
Volume	8,269,201
Avg. volume	13,895,154

Market cap	69.24B
Beta (3Y monthly)	1.19
PE ratio (TTM)	N/A
EPS (TTM)	-0.57
Earnings date	30 Apr 2019 - 6 May 2019
Forward dividend & yield	2.00 (3.46%)
Ex-dividend date	2019-04-22
1y target est	73.04

Trade prices are not sourced from all markets

All

News

Press Releases

GlobeNewswireyesterday
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS CVS, ARA, CTL, KHC INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
NEW ORLEANS, April 22, 2019 -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending.
GlobeNewswireyesterday
CLASS ACTION UPDATE for T, CAG, CVS and INGN: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
NEW YORK, April 22, 2019 -- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies..
Motley Fool2 days ago
Better Buy: Walgreens Boots Alliance vs. CVS Health
Which of these major pharmacy retailers is more likely to be the bigger long-term winner?
GlobeNewswire4 days ago
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS CVS, CAG, KHC, BPI INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
NEW ORLEANS, April 19, 2019 -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending.
GlobeNewswire5 days ago
CVS DEADLINE: Pawar Law Group Announces a Securities Class Action Lawsuit Against CVS Health Corporation – CVS
Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of CVS Health Corporation (CVS) from May 21, 2015 through February 20, 2019, inclusive (the “Class Period”). To join the CVS class action, go to http://pawarlawgroup.com/cases/cvs-health-corporation/ or call Vik Pawar, Esq.
GlobeNewswire5 days ago
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in CVS Health Corporation of Class Action Lawsuit and Upcoming Deadline – CVS
Pomerantz LLP announces that a class action lawsuit has been filed against CVS Health Corporation (“CVS” or the “Company”) (CVS) and certain of its officers and directors. The class action, filed in United States District Court, Southern District of New York, and indexed under 19-cv-01725, is on behalf of a class consisting of all persons and entities, other than Defendants and their affiliates, who purchased or otherwise acquired CVS Health securities between May 21, 2015 and February 20, 2019, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.
GlobeNewswire5 days ago
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS DPLO, BA, CVS, BPI INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
NEW ORLEANS, April 18, 2019 -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending.
GlobeNewswire6 days ago
CLASS ACTION UPDATE for CVS, UMC, NTNX and BA: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
NEW YORK, April 17, 2019 -- Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies..
Barrons.com6 days ago
CVS CEO Larry Merlo on Health Care, New Clinics — and Those Crazy Long Receipts
CVS CEO Larry Merlo oversees the country’s largest chain of drugstores and walk-in clinics, and a major pharmacy benefit manager. We talked to him about the future of the company.
Zacks7 days ago
CVS Health (CVS) Stock Sinks As Market Gains: What You Should Know
In the latest trading session, CVS Health (CVS) closed at $53.90, marking a -0.59% move from the previous day.
Associated Press7 days ago
CVS fined $535K for filling forged Percocet prescriptions
PROVIDENCE, R.I. (AP) — Drugstore chain CVS Health has agreed to pay $535,000 to resolve federal allegations that it filled dozens of Percocet prescriptions its pharmacists should have known were forged.
Market Realist7 days ago
What Analyst Ratings Indicate for CVS Stock
Oppenheimer Downgrades CVS Health Stock to 'Perform'(Continued from Prior Part)Analysts suggest “buy” Among the 27 analysts covering CVS Health (CVS) stock, 18 analysts suggest a “buy,” and nine analysts recommend a “hold.” Analysts have
Market Realist7 days ago
Oppenheimer Downgrades CVS Health Stock to ‘Perform’
Oppenheimer Downgrades CVS Health Stock to 'Perform'Near-term headwinds to set the directionOn April 15, Oppenheimer downgraded CVS Health (CVS) stock to “perform” from “outperform” and removed its price target of $85. CVS Health’s
Barrons.com7 days ago
CVS CEO Larry Merlo on the Aetna Deal and the Future of Health Care
What does the long-term opportunity look like for CVS to transform health care? We talked to CVS CEO Larry Merlo about the future of the industry.
Barrons.com8 days ago
The Dow Loses 59 Points Because Earnings Are a Mixed Bag
A mixed bag of earnings results left investors less enthusiastic as they await economic data and any updates on U.S.-China trade negotiations.
Reuters8 days ago
US STOCKS-Wall Street slips as big bank results disappoint
Wall Street's main indexes fell on Monday, pulling back from a rally in the prior session that took the S&P 500 within striking distance of its September record close, as lackluster results from Goldman Sachs and Citigroup pressured financial stocks. Goldman Sachs Group Inc fell 3.2% and Citigroup Inc dipped 0.9% after both Wall Street banks missed revenue estimates.
GlobeNewswire8 days ago
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS DPLO, BA, CVS, CTL INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
NEW ORLEANS, April 15, 2019 -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending.
Barrons.com8 days ago
CVS Stock Is Gaining Despite Being Downgraded. Here’s Why.
Oppenheimer analyst Michael Wiederhorn lowered his rating of CVS to Perform from Outperform, but Barron’s was bullish on the stock.
Reuters8 days ago
US STOCKS-Wall Street dips after lackluster big bank earnings
U.S. stocks slipped on Monday, weighed by losses in financial stocks as earnings from Wall Street's big banks Goldman Sachs and Citigroup failed to impress. Goldman Sachs Group Inc fell 2.6%, while Citigroup Inc declined 1%.
Barrons.com8 days ago
How CVS Wants to Fix Health Care — and Why It’s Time to Buy the Stock.
With newly acquired Aetna, a pharmacy benefit manager, and a giant chain of stores, this company is well positioned for a future in which consumers gain more power over their care
Motley Fool10 days ago
Is a Target and CVS Merger Now Inevitable?
These two companies are dancing closer to each other every day.
GlobeNewswire11 days ago
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS DPLO, INGN, CVS, WTW INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
NEW ORLEANS, April 12, 2019 -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending.
GlobeNewswire12 days ago
SHAREHOLDER ALERT: KHC CVS CTL BPI: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
NEW YORK, April 11, 2019 -- The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a.
Associated Press12 days ago
Rite Aid cuts 95% of outstanding shares to hit NYSE minimum
Rite Aid will chop its share count by about 95% in a bid to push the remaining shares above minimum trading requirements on the New York Stock Exchange. The board of the struggling drugstore chain approved a 1-for-20 ratio for a reverse stock split after shareholders backed the plan last month. The drugstore chain said Wednesday after markets closed that on April 22, its shares will start trading on a split-adjusted basis.
GlobeNewswire13 days ago
SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS CVS, WTW, CTL, CAG INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits
NEW ORLEANS, April 10, 2019 -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors of pending.